{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:05:41Z","timestamp":1790060741816,"version":"4.0.1"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pain Med"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1093\/pm\/pnw129","type":"journal-article","created":{"date-parts":[[2016,7,4]],"date-time":"2016-07-04T00:07:49Z","timestamp":1467590869000},"page":"78-85","source":"Crossref","is-referenced-by-count":33,"title":["ER\/LA Opioid Analgesics REMS: Overview of Ongoing Assessments of Its Progress and Its Impact on Health Outcomes"],"prefix":"10.1093","volume":"18","author":[{"given":"M. Soledad","family":"Cepeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Coplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan W.","family":"Kopper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Maziere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory P.","family":"Wedin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,7,2]]},"reference":[{"key":"2017013103450955000_18.1.78.1","unstructured":"Executive Office of the President of the United States. Epidemic: Responding to America\u2019s prescription drug abuse crisis. Executive Office of the President of the United States; 2011. Available at: http:\/\/www.whitehouse.gov\/sites\/default\/files\/ondcp\/ issues-content\/prescription-drugs\/rx_abuse_plan_0.pdf (accessed August 8 2015)."},{"key":"2017013103450955000_18.1.78.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1011512"},{"key":"2017013103450955000_18.1.78.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.272"},{"key":"2017013103450955000_18.1.78.4","unstructured":"FDA. Risk Evaluation and Mitigation Strategy (REMS) for Extended-Release and Long-Acting Opioids. Silver Spring, MD: FDA; 2015."},{"key":"2017013103450955000_18.1.78.5","unstructured":"ER\/LA Opioid Analgesics REMS. Available at: http:\/\/www.er-la-opioidrems.com\/IwgUI\/rems\/home.action (accessed August 3 2015)."},{"key":"2017013103450955000_18.1.78.6","unstructured":"FDA. FDA Blueprint for Prescriber Education for Extended-Release and Long-Acting Opioid Analgesics. FDA; 2014. Available at: http:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/InformationbyDrugClass\/ucm 277916.pdf (accessed 3 2015)."},{"key":"2017013103450955000_18.1.78.7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2006.00259.x"},{"key":"2017013103450955000_18.1.78.8","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1659"},{"key":"2017013103450955000_18.1.78.9","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jpain.2012.08.008","article-title":"Abuse rates and routes of administration of reformulated extended-release oxycodone: Initial findings from a sentinel surveillance sample of individuals assessed for substance abuse treatment","volume":"14","author":"Butler","year":"2013","journal-title":"J Pain"},{"key":"2017013103450955000_18.1.78.10","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12459"},{"key":"2017013103450955000_18.1.78.11","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e318249d6e7"},{"key":"2017013103450955000_18.1.78.12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/01.JAA.0000443969.69352.4a","article-title":"Supply of physician assistants: 2013-2026","volume":"27","author":"Hooker","year":"2014","journal-title":"JAAPA"},{"key":"2017013103450955000_18.1.78.13","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6450a3"},{"key":"2017013103450955000_18.1.78.14","unstructured":"The White House. Prescription Drug Abuse. Washington, DC: Office of National Drug Control Policy. Available at: http:\/\/www.whitehouse.gov\/ondcp\/ prescription-drug-abuse1 (accessed August 4 2015)."},{"key":"2017013103450955000_18.1.78.15","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/pds.3666","article-title":"Prescriber response to unsolicited prescription drug monitoring program reports in Massachusetts","volume":"23","author":"Thomas","year":"2014","journal-title":"Pharmaco epidemiol Drug Saf"},{"key":"2017013103450955000_18.1.78.16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2012.01327.x"},{"key":"2017013103450955000_18.1.78.17","unstructured":"Society MM. Continuing Medical Education Requirements for Physician License Renewal in Massachusetts. Waltham, MA: Massachusetts Medical Society; 2015."},{"key":"2017013103450955000_18.1.78.18","unstructured":"GroupHealth. Chronic Opioid Therapy Safety Guideline for Patients With Chronic Non-Cancer Pain. GroupHealth; 2014. Available at: http:\/\/www.ghc.org\/all-sites\/guidelines\/chronicOpioid.pdf (accessed August 19 2015)."},{"key":"2017013103450955000_18.1.78.19","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.0914"},{"key":"2017013103450955000_18.1.78.20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1406143"},{"key":"2017013103450955000_18.1.78.21","unstructured":"United States Food and Drug Administration. Postmarketing Requirements for the Class-Wide Extended-Release\/Long-Acting Opioid Analgesics. Silver Spring, MD: FDA; 2014."}],"container-title":["Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/painmedicine\/article-pdf\/18\/1\/78\/9994844\/pnw129.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T16:42:33Z","timestamp":1568133753000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/painmedicine\/article-lookup\/doi\/10.1093\/pm\/pnw129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,2]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1,31]]},"published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.1093\/pm\/pnw129"],"URL":"https:\/\/doi.org\/10.1093\/pm\/pnw129","relation":{},"ISSN":["1526-2375","1526-4637"],"issn-type":[{"value":"1526-2375","type":"print"},{"value":"1526-4637","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,2]]}}}